QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

EOLS

QT82Evolus, Inc.
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic·USA
Latest market price
6.63
-0.11-1.63%
OverviewShort InterestFilings
EOLSQT82Evolus, Inc.·NASDAQ
OverviewShort InterestFilings
6.63-1.63%
TA
Loading chart...
Screen all →
TAK+1.36%$15.63HLN+1.01%$8.96TEVA-3.32%$31.48VTRS-2.29%$15.37ELAN+3.55%$24.22RDY+1.06%$13.29RGC-18.96%$12.01LNTH+0.65%$103.86
Snapshot
Index-P/E-EPS (ttm)
-0.92
Insider Own-
Shs Outstand65.85M
Perf Week1.84%
Market Cap443.86MForward P/E24.86EPS next Y0.27Insider Trans-0.04%Shs Float-Perf Month3.11%
Enterprise Value558.97MPEG-EPS next Q-0.01Inst Own-Short Float-Perf Quarter36.42%
Income-43853469.00P/S1.47EPS this Y90.74%Inst Trans-Short Ratio-Perf Half Y-8.17%
Sales301.79MP/B-EPS next Y413.06%ROA-19.68%Short Interest-Perf YTD-0.30%
Book/sh-0.44P/C-EPS next 5Y-ROE174.92%52W High10.20 -35.00%Perf Year-28.32%
Cash/sh0.76P/FCF-EPS past 3/5Y-ROIC-18.60%52W Low3.86 71.76%Perf 3Y-
Dividend Est.-EV/EBITDA-39.84Sales past 3/5Y25.85% 39.12%Gross Margin65.55%Volatility3.45% 3.30%Perf 5Y-
Dividend TTM-EV/Sales1.85EPS Y/Y TTM46.20%Oper. Margin-9.56%ATR (14)0.33Perf 10Y-
Dividend Ex-Date-Quick Ratio1.68Sales Y/Y TTM7.52%Profit Margin-14.39%RSI (14)56.07Recom2.15
Dividend Gr. 3/5Y-Current Ratio2.04EPS Q/Q44.44%SMA201.86%Beta1.13Target Price15.00
Payout0.00%Debt/Eq-5.73Sales Q/Q5.80%SMA5011.71%Rel Volume1.30Prev Close6.74
Employees372LT Debt/Eq-6.61EarningsAug 04SMA20012.24%Avg Volume847.22KPrice6.63
IPO DateFeb 08, 2018Option/ShortYes / YesEPS/Sales Surpr.28.57% 0.00%Net Debt/EBITDA-8.20Volume1,101,780Change-1.63%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-04-26ReiteratedMizuho Securities$19 → $15
Jan-22-26ReiteratedBTIGBuy$13
Jan-13-26ReiteratedStifel Nicolaus$20 → $17
Dec-01-25ReiteratedMizuho Securities$25 → $19
Aug-06-25DowngradeNeedhamBuy → Hold
Oct-03-24ReiteratedH.C. WainwrightBuy$27
Sep-13-24ReiteratedMizuho Securities$25
Sep-13-24ReiteratedBarclaysOverweight$16 → $20
Jan-29-24UpgradeBarclaysEqual Weight → Overweight$16
May-13-22UpgradeBarclaysUnderweight → Equal Weight
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue286297266
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A9810484
Gross Profit188193182
Selling, General and Administrative Excl. Other217221198
Research and Development8109
Other Operating Expense3-110
Operating Income-38-38-34
Interest Expense202019
Unusual Expense
———
Non-Operating Income (Expense)-3-6-3
Net Income Before Taxes-58-51-50
Income Taxes011
Consolidated Net Income-59-52-50
Net Income From Continuing Operations-59-52-50
Net Income-59-52-50
EPS (Recurring)-0.92-0.80-0.81
EPS (Basic, Before Extraordinaries)-0.92-0.80-0.81
EPS (Diluted)-0.92-0.80-0.81
EBITDA-30-23-25
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio1.511.43—
Gross Margin65.7364.9868.42
Operating Margin-13.29-12.79-12.78
Net Margin-20.63-17.51-18.80
Shares Outstanding656462
Market Capitalization431426—
Operating Lease Expense
———
Insider Trading Volume
$7.00$6.22$5.43$4.65$3.87● Close Price0.00M0.32M0.64M0.96M1.28MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Avelar RuiSee RemarksMar 20 '26Sale4.753,11914,815427,423Mar 20 12:00 AM
MOATAZEDI DAVIDSee RemarksMar 20 '26Sale4.7513,66964,929604,700Mar 20 12:00 AM
Avelar RuiSee RemarksMar 17 '26Sale4.8929,996146,629430,542Mar 18 12:00 AM
MOATAZEDI DAVIDSee RemarksMar 17 '26Sale4.89116,720570,562618,369Mar 18 12:00 AM
Avelar RuiSee RemarksMar 16 '26Option Exercise0.0017,6080460,538Mar 18 12:00 AM
MOATAZEDI DAVIDSee RemarksMar 16 '26Option Exercise0.00134,9780735,089Mar 18 12:00 AM
MOATAZEDI DAVIDSee RemarksDec 22 '25Sale7.1510,53975,361354,388Dec 29 12:00 AM
Avelar RuiSee RemarksDec 22 '25Sale7.152,26116,168356,821Dec 29 12:00 AM
Yamagishi-Dressler TomokoChief Marketing OfficerAug 22 '25Sale7.515,72242,97289,949Aug 26 12:00 AM
Stewart BradyDirectorAug 15 '25Buy6.8230,000204,48688,629Aug 18 12:00 AM
MOATAZEDI DAVIDSee RemarksJun 16 '25Sale9.8916,582164,054364,927Jun 16 12:00 AM
MOATAZEDI DAVIDSee RemarksJun 13 '25Sale10.05111,3231,119,141381,509Jun 16 12:00 AM
White Albert G IIIDirectorJun 09 '25Buy9.4520,000189,00050,378Jun 10 12:00 AM
Beaver SandraChief Financial OfficerMay 13 '25Sale10.026,49465,070167,089May 14 12:00 AM
Avelar RuiSee RemarksMay 12 '25Sale9.873,38533,397359,082May 14 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR